Hi,
thanks for the reply. That is the target id. From miRDB:
mmu-miR-669f-3p NM_001042565 99.7800236967459
I suppose I could get around the ensembl id's by using gene name, but I still need a way to bulk convert the id's to gene names.
Unconfigured Ad
Collapse
X
-
Took a quick look at both Ensembl and Ncbi considering the transcript "NM_001042565". I tried its gene "Wsb1" to get all the transcript information.
NM_001042565.3 = ENSMUST00000017821 (Wsb1-001)
NM_019653.3 however, has no corresponding Ensembl transcript.
This would probably be why NM_001042565 doesn't get converted, since biomart would not contain an id-id mapping information for such transcript.
Anyway, what does the original "miRDB target id" look like?
Leave a comment:
-
converting mirDB target ids to ensembl ids
Hi,
I have about 3000 miRNA targets from miRDB. I am needing to convert the target identifiers into Ensembl ids (mouse btw). About 2k of these convert using biomaRt in R. The other 1k I am not sure how to handle programmatically as I can't figure out what id type they are.
Most convert using either refseq_mrna (Refseq mRNA ID(s) [e.g. NM_001195244]) or refseq_mrna_predicted (Refseq Predicted mRNA ID(s) [e.g. XM_889253])
An example of one that doesn't convert: "NM_001042565". Looking this up in Ensembl via the main search I get "novel transcript (Mouse Transcript)". So I know it is there. I have taken the identifier and tried to convert it using Ensembl's BioMart using the filter option with most of the gene/transcript looking options and do not get anything back.
What filter option should I use to get all the miRDB target id's to convert to Ensembl IDs???
Thanks,
BobTags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
39 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
45 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: